Literature DB >> 28856860

The effect of exercise on high-intensity focused ultrasound treatment efficacy in uterine fibroids and adenomyosis: a retrospective study.

X Huang1, D Yu2, M Zou2, L Wang2, H R Xing3, Z Wang1.   

Abstract

OBJECTIVE: We conducted a retrospective study to evaluate whether exercise after high-intensity focused ultrasound (HIFU) treatment can improve the absorption of uterine fibroids and the relief of dysmenorrhea caused by adenomyosis.
DESIGN: A retrospective study.
SETTING: Gynaecological department of a single centre in China. POPULATION: Patients with uterine fibroids and adenomyosis.
METHOD: From January 2011 to August 2015,83 MRI-confirmed uterine fibroid patients and 102 adenomyosis patients who received HIFU treatment at Chongqing Haifu Hospital and attended the 1-year and 6-month follow up, respectively, were included in our retrospective study. Among the fibroid patients, 51 were assigned to the 'no exercise group' and 32 to the 'exercise group'. Among the adenomyosis patients, 45 were assigned to the 'no exercise group' and to the 57 'exercise group'. MAIN OUTCOME MEASURES: Symptom improvement, uterine fibroid volume and Visual Analogue Scale (VAS) evaluation.
RESULTS: Exercise post-HIFU treatment significantly improved the absorption of uterine fibroids, reduced recurrence rate and increased the rate of pregnancy in uterine fibroid patients. Exercise lead to a more significant reduction in the score of dysmenorrhea.
CONCLUSION: Exercise post-HIFU treatment demonstrated an enhancement of the therapeutic efficacy of HIFU for both uterine fibroid patients and adenomyosis patients. Therefore, exercise should be recommended to patients as part of the post-treatment disease management plan. TWEETABLE ABSTRACT: A retrospective study evaluated the effect of exercise after high-intensity focused ultrasound (HIFU) treatment on the therapeutic efficacy of HIFU.
© 2017 Royal College of Obstetricians and Gynaecologists.

Entities:  

Keywords:  Adenomyosis; exercise; high-intensity focused ultrasound; uterine fibroids

Mesh:

Year:  2017        PMID: 28856860     DOI: 10.1111/1471-0528.14748

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  2 in total

Review 1.  A systematic review of outcome reporting and outcome measures in studies investigating uterine-sparing treatment for adenomyosis.

Authors:  T Tellum; M Omtvedt; J Naftalin; M Hirsch; D Jurkovic
Journal:  Hum Reprod Open       Date:  2021-08-07

2.  Immunoreactivity of Plasminogen Activator Inhibitor 1 and Its Correlation with Dysmenorrhea and Lesional Fibrosis in Adenomyosis.

Authors:  Bingxin Yang; Nihao Gu; Shu Shi; Chen Zhang; Lan Chen; Jing Ouyang; Yu Lin; Feng Sun; Hong Xu
Journal:  Reprod Sci       Date:  2021-03-08       Impact factor: 3.060

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.